MALAT1 and cancer: In different types of cancer, it has also been found that lncRNAs can be directly evaluated in biological fluids through the optimization of PCR-based procedures in order to detect even very low amounts in the bloodstream, as reported for MALAT1 [143,144], which represents a valid biomarker to be used in clinical practice.